{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:05:04Z","timestamp":1761599104166},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,8,23]],"date-time":"2011-08-23T00:00:00Z","timestamp":1314057600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1245\/s10434-011-1992-9","type":"journal-article","created":{"date-parts":[[2011,8,23]],"date-time":"2011-08-23T13:23:02Z","timestamp":1314105782000},"page":"734-742","source":"Crossref","is-referenced-by-count":4,"title":["XPC mRNA Level May Predict Relapse in Never-smokers with Non-Small Cell Lung Cancers"],"prefix":"10.1245","volume":"19","author":[{"given":"Kun-Tu","family":"Yeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Hui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Ching","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Te","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huei","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,8,23]]},"reference":[{"key":"1992_CR1","doi-asserted-by":"crossref","first-page":"5646","DOI":"10.1158\/1078-0432.CCR-09-0377","volume":"15","author":"CM Rudin","year":"2009","unstructured":"Rudin CM, Avila-Tang E, Harris CC, et al. Lung cancer in never smokers: molecular profiles and therapeutic implications. Clin Cancer Res. 2009;15:5646\u201361.","journal-title":"Clin Cancer Res."},{"key":"1992_CR2","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1158\/1078-0432.CCR-09-0376","volume":"15","author":"JM Samet","year":"2009","unstructured":"Samet JM, Avila-Tang E, Boffetta P, et al. Lung cancer in never smokers: clinical epidemiology and environmental risk factors. Clin Cancer Res. 2009;15:5626\u201345.","journal-title":"Clin Cancer Res."},{"key":"1992_CR3","doi-asserted-by":"crossref","first-page":"5622","DOI":"10.1158\/1078-0432.CCR-09-0373","volume":"15","author":"CM Rudin","year":"2009","unstructured":"Rudin CM, Avila-Tang E, Samet JM. Lung cancer in never smokers: a call to action. Clin Cancer Res. 2009;15:5622\u20135.","journal-title":"Clin Cancer Res."},{"key":"1992_CR4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1200\/JCO.2006.06.8015","volume":"25","author":"J Subramanian","year":"2007","unstructured":"Subramanian J, Govindan R. Lung cancer in never smokers: a review. J Clin Oncol. 2007;25:561\u201370.","journal-title":"J Clin Oncol."},{"key":"1992_CR5","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/nrc2190","volume":"7","author":"S Sun","year":"2007","unstructured":"Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers\u2014a different disease. Nat Rev Cancer. 2007;7:778\u201390.","journal-title":"Nat Rev Cancer."},{"key":"1992_CR6","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1200\/JCO.2006.07.2983","volume":"25","author":"HA Wakelee","year":"2007","unstructured":"Wakelee HA, Chang ET, Gomez SL, et al. Lung cancer incidence in never smokers. J Clin Oncol. 2007;25:472\u20138.","journal-title":"J Clin Oncol."},{"key":"1992_CR7","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1200\/JCO.2005.04.8033","volume":"24","author":"CK Toh","year":"2006","unstructured":"Toh CK, Gao F, Lim WT, et al. Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity. J Clin Oncol. 2006;24:2245\u201351.","journal-title":"J Clin Oncol."},{"key":"1992_CR8","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/JTO.0b013e3181e2f607","volume":"5","author":"T Kawaguchi","year":"2010","unstructured":"Kawaguchi T, Matsumura A, Fukai S, et al. Japanese ethnicity compared with Caucasian ethnicity and never-smoking statuses are independent favorable prognostic factors for overall survival in non-small cell lung cancer: a collaborative epidemiologic study of the National Hospital Organization Study Group for Lung Cancer (NHSGLC) in Japan and a Southern California Regional Cancer Registry databases. J Thorac Oncol. 2010;5:1001\u201310.","journal-title":"J Thorac Oncol."},{"key":"1992_CR9","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/JTO.0b013e3181b27b15","volume":"4","author":"SH Ou","year":"2009","unstructured":"Ou SH, Ziogas A, Zell JA. Asian ethnicity is a favorable prognostic factor for overall survival in non-small cell lung cancer (NSCLC) and is independent of smoking status. J Thorac Oncol. 2009;4:1083\u201393.","journal-title":"J Thorac Oncol."},{"key":"1992_CR10","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/JTO.0b013e3181dc213e","volume":"5","author":"T Kawaguchi","year":"2010","unstructured":"Kawaguchi T, Takada M, Kubo A, et al. Gender, histology, and time of diagnosis are important factors for prognosis: analysis of 1499 never-smokers with advanced non-small cell lung cancer in Japan. J Thorac Oncol. 2010;5:1011\u20137.","journal-title":"J Thorac Oncol."},{"key":"1992_CR11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00595-007-3599-0","volume":"38","author":"H Nakamura","year":"2008","unstructured":"Nakamura H, Haruki T, Adachi Y, et al. Smoking affects prognosis after lung cancer surgery. Surg Today. 2008;38:227\u201331.","journal-title":"Surg Today."},{"key":"1992_CR12","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/JTO.0b013e318186fafb","volume":"3","author":"T Hanagiri","year":"2008","unstructured":"Hanagiri T, Sugio K, Mizukami M, et al. Significance of smoking as a postoperative prognostic factor in patients with non-small cell lung cancer. J Thorac Oncol. 2008;3:1127\u201332.","journal-title":"J Thorac Oncol."},{"key":"1992_CR13","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/cncr.23679","volume":"113","author":"T Yano","year":"2008","unstructured":"Yano T, Miura N, Takenaka T, et al. Never-smoking nonsmall cell lung cancer as a separate entity. Cancer. 2008;113:1012\u20138.","journal-title":"Cancer."},{"key":"1992_CR14","doi-asserted-by":"crossref","unstructured":"Bryant A, Cerfolio RJ. Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer. Chest. 2007;132:185\u201392.","DOI":"10.1378\/chest.07-0442"},{"key":"1992_CR15","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1056\/NEJMra035536","volume":"350","author":"A Spira","year":"2004","unstructured":"Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med. 2004;350:379\u201392.","journal-title":"N Engl J Med."},{"key":"1992_CR16","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1378\/chest.122.3.1037","volume":"122","author":"MD Brundage","year":"2002","unstructured":"Brundage MD, Davies D, Mackillop WJ. Prognostic factors in non-small cell lung cancer: a decade of progress. Chest. 2002;122:1037\u201357.","journal-title":"Chest."},{"key":"1992_CR17","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1200\/JCO.2004.04.109","volume":"22","author":"H Endoh","year":"2004","unstructured":"Endoh H, Tomida S, Yatabe Y, et al. Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction. J Clin Oncol. 2004;22:811\u20139.","journal-title":"J Clin Oncol."},{"key":"1992_CR18","first-page":"3005","volume":"62","author":"DA Wigle","year":"2002","unstructured":"Wigle DA, Jurisica I, Radulovich N, et al. Molecular profiling of non-small cell lung cancer and correlation with disease-free survival. Cancer Res. 2002;62:3005\u20138.","journal-title":"Cancer Res."},{"key":"1992_CR19","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/nm733","volume":"8","author":"DG Beer","year":"2002","unstructured":"Beer DG, Kardia SL, Huang CC, et al. Gene-expression profiles predict survival of patients with adenocarcinoma. Nat Med. 2002;8:816\u201324.","journal-title":"Nat Med."},{"key":"1992_CR20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1054\/bjoc.2000.1287","volume":"83","author":"PM Schneider","year":"2000","unstructured":"Schneider PM, Praeuer HW, Stoeltzing O, et al. Multiple molecular marker testing (p53, c-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer. Br J Cancer. 2000;83:473\u20139.","journal-title":"Br J Cancer."},{"key":"1992_CR21","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/cncr.22743","volume":"110","author":"YH Wu","year":"2007","unstructured":"Wu YH, Cheng YW, Chang Tsai JH, et al. Reduced XPC messenger RNA level may predict a poor outcome of patients with non-small cell lung cancer. Cancer. 2007;110:215\u201323.","journal-title":"Cancer."},{"key":"1992_CR22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.mrfmmm.2009.08.004","volume":"685","author":"K Sugasawa","year":"2010","unstructured":"Sugasawa K. Regulation of damage recognition in mammalian global genomic nucleotide excision repair. Mutat Res. 2010;685:29\u201337.","journal-title":"Mutat Res."},{"key":"1992_CR23","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1038\/emboj.2009.187","volume":"28","author":"U Camenisch","year":"2009","unstructured":"Camenisch U, Trautlein D, Clement FC, et al. Two-stage dynamic DNA quality check by xeoderma pigmentosum group C protein. EMBO J. 2009;28:2387\u201399.","journal-title":"EMBO J."},{"key":"1992_CR24","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1038\/sj.emboj.7601277","volume":"25","author":"M D\u2019Errico","year":"2006","unstructured":"D\u2019Errico M, Parlanti E, Teson M, et al. New functions of XPC in the protection of human skin cells from oxidative damage. EMBO J. 2006;25:4305\u201315.","journal-title":"EMBO J."},{"key":"1992_CR25","first-page":"771","volume":"59","author":"DL Cheo","year":"1999","unstructured":"Cheo DL, Burns DK, Meira LB, et al. Mutational inactivation of the xeroderma pigmentosum group C gene confers predisposition to 2-acetylaminofluorene-induced liver and lung cancer and to spontaneous testicular cancer in Trp53\u2212\/\u2212 mice. Cancer Res. 1999;59:771\u20135.","journal-title":"Cancer Res."},{"key":"1992_CR26","doi-asserted-by":"crossref","first-page":"13200","DOI":"10.1073\/pnas.0503133102","volume":"102","author":"MC Hollander","year":"2005","unstructured":"Hollander MC, Philburn RT, Patterson AD, et al. Deletion of XPC leads to lung tumors in mice and is associated with early events in human lung carcinogenesis. Proc Natl Acad Sci USA. 2005;102:13200\u20135.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"1992_CR27","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1038\/sj.onc.1210284","volume":"26","author":"YH Wu","year":"2007","unstructured":"Wu YH, Chang Tsai JH, Cheng YW, et al. Xeroderma pigmentosum group C gene expression is predominantly regulated by promoter hypermethylation and contributes to p53 mutation in lung cancers. Oncogene. 2007;26:4761\u201373.","journal-title":"Oncogene."},{"key":"1992_CR28","doi-asserted-by":"crossref","first-page":"10422","DOI":"10.1158\/0008-5472.CAN-10-2615","volume":"70","author":"YH Wu","year":"2010","unstructured":"Wu YH, Wu TC, Liao JW, Yeh KT, et al. p53 dysfunction by xeroderma pigmentosum group C defects enhances lung adenocarcinoma metastasis via increased MMP1 expression. Cancer Res. 2010;70:10422\u201332.","journal-title":"Cancer Res."},{"key":"1992_CR29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/ajcp\/77.2.123","volume":"77","author":"World Health Organization","year":"1982","unstructured":"World Health Organization. Histological typing of lung tumors. Am J Clin Pathol. 1982;77:123\u201336.","journal-title":"Am J Clin Pathol"},{"key":"1992_CR30","doi-asserted-by":"crossref","first-page":"225s","DOI":"10.1378\/chest.89.4_Supplement.225S","volume":"89","author":"CF Moutain","year":"1986","unstructured":"Moutain CF. A new international staging system for lung cancer. Chest. 1986;89:225s\u201333s.","journal-title":"Chest."},{"key":"1992_CR31","first-page":"115","volume-title":"Manual for staging of cancer","author":"OH Behars","year":"1992","unstructured":"Behars OH, Henson DE, Myers HH. Manual for staging of cancer. 4th ed. Philadelphia, PA: American Joint Committee on Cancer; 1992. p. 115\u201322.","edition":"4"},{"key":"1992_CR32","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1470-2045(07)70279-6","volume":"8","author":"A Ramirez de Molina","year":"2007","unstructured":"Ramirez de Molina A, Sarmentero-Estrada J, Belda-Iniesta C, et al. Expression of choline kinase alpha to predict outcome in patients with early-stage non-small cell lung cancer: a retrospective study. Lancet Oncol. 2007;8:889\u201397.","journal-title":"Lancet Oncol."},{"key":"1992_CR33","first-page":"327","volume":"7","author":"J Subramanian","year":"2010","unstructured":"Subramanian J, Simon R. What should physicians look for in evaluating prognostic gene-expression signatures? Nat Med. 2010;7:327\u201334.","journal-title":"Nat Med."},{"key":"1992_CR34","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/jnci\/djq025","volume":"102","author":"J Subramanian","year":"2010","unstructured":"Subramanian J, Simon R. Gene expression-based prognostic signatures in lung cancer: ready for clinical use? J Natl Cancer Inst. 2010;102:464\u201374.","journal-title":"J Natl Cancer Inst."},{"key":"1992_CR35","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1200\/JCO.2004.12.002","volume":"22","author":"G Bepler","year":"2004","unstructured":"Bepler G, Sharma S, Cantor A, et al. RRM1 and PETN as prognostic parameters for overall and disease-free survival in patients with non-small cell lung cancer. J Clin Oncol. 2004;22:1878\u201385.","journal-title":"J Clin Oncol."},{"key":"1992_CR36","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1378\/chest.127.3.978","volume":"127","author":"GR Simon","year":"2005","unstructured":"Simon GR, Sharma S, Cantor A, et al. ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancer. Chest. 2005;127:978\u201388.","journal-title":"Chest."},{"key":"1992_CR37","doi-asserted-by":"crossref","unstructured":"Su C, Zhou S, Zhang L, et al. ERCC1, RRM1 and BRCA1 mRNA expression levels and clinical outcome of advanced non-small cell lung cancer. Med Oncol. 2010. doi: 10.1007\/s12032-010-9553-9 .","DOI":"10.1007\/s12032-010-9553-9"},{"key":"1992_CR38","doi-asserted-by":"crossref","first-page":"e1129","DOI":"10.1371\/journal.pone.0001129","volume":"2","author":"R Rosell","year":"2007","unstructured":"Rosell R, Skrzypski M, Jassem E, et al. BRCA1: a novel prognostic factor in resected non-small cell lung cancer. PLoS One. 2007;2:e1129.","journal-title":"PLoS One"},{"key":"1992_CR39","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/sj.onc.1206232","volume":"22","author":"A Gautam","year":"2003","unstructured":"Gautam A, Li ZR, Bepler G. RRM1-induced metastasis suppression through PTEN-regulated pathways. Oncogene. 2003;22:2135\u201342.","journal-title":"Oncogene."},{"key":"1992_CR40","doi-asserted-by":"crossref","first-page":"13181","DOI":"10.1073\/pnas.94.24.13181","volume":"94","author":"H Fan","year":"1997","unstructured":"Fan H, Huang A, Villegas C, Wright JA. The R1 component of mammalian ribonucleotide reductase has malignancy-suppressing activity as demonstrated by gene transfer experiments. Proc Natl Acad Sci USA. 1997;94:13181\u20136.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"1992_CR41","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.1158\/0008-5472.CAN-05-4462","volume":"66","author":"A Gautam","year":"2006","unstructured":"Gautam A, Bepler G. Suppression of lung tumor formation by the regulatory subunit of ribonucleotide reductase. Cancer Res. 2006;66:6497\u2013502.","journal-title":"Cancer Res."},{"key":"1992_CR42","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.juro.2010.03.044","volume":"184","author":"J Yang","year":"2010","unstructured":"Yang J, Xu Z, Li J, et al. XPC epigenetic silence coupled with p53 alternation has a significant impact on bladder cancer outcome. J Urol. 2010;184:336\u201343.","journal-title":"J Urol."},{"key":"1992_CR43","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.lungcan.2009.12.007","volume":"69","author":"M Li","year":"2010","unstructured":"Li M, Xiao T, Zhang Y, et al. Prognostic significance of matrix metalloproteinase-1 levels in peripheral plasma and tumor tissues of lung cancer patients. Lung Cancer. 2010;69:341\u20137.","journal-title":"Lung Cancer."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-011-1992-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-011-1992-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-011-1992-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T11:44:40Z","timestamp":1572954280000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-011-1992-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,23]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["1992"],"URL":"https:\/\/doi.org\/10.1245\/s10434-011-1992-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,23]]}}}